Metapneumonia RNA Detection Qualitative Test
At DNA Labs UAE, we offer the Metapneumonia RNA Detection Qualitative Test to diagnose viral respiratory infection caused by the metapneumovirus. This test is a diagnostic tool used to detect the presence of metapneumovirus RNA in a patient’s respiratory sample.
Test Details
The Metapneumonia RNA Detection Qualitative Test is performed using a technique called reverse transcription-polymerase chain reaction (RT-PCR). This method involves the conversion of the viral RNA into complementary DNA (cDNA) using an enzyme called reverse transcriptase. The cDNA is then amplified using PCR, which makes multiple copies of the target viral RNA sequence.
A respiratory sample, such as a nasal swab or sputum, is collected from the patient. The sample is then processed in the laboratory to extract the viral RNA. The extracted RNA is converted into cDNA using reverse transcriptase, and the cDNA is amplified using PCR. If the metapneumovirus RNA is present in the sample, the amplification process will generate a specific DNA product that can be detected using various methods, such as gel electrophoresis or fluorescent probes.
The presence of the DNA product indicates a positive result, indicating that the patient is infected with metapneumovirus. The RNA detection qualitative test is highly sensitive and specific, allowing for the early and accurate diagnosis of metapneumonia. It is particularly useful in detecting the virus in patients with mild or asymptomatic infections, who may not exhibit obvious symptoms but can still transmit the virus to others.
Test Components and Price
The Metapneumonia RNA Detection Qualitative Test includes the following components:
- Bronchial Swab
- Bronchial Lavage
- Sputum
- Nasopharyngeal (NP) aspirates and swabs in viral transport medium
- Lung tissues, ETC.
The cost of the test is AED 1160.0.
Symptoms and Diagnosis
Metapneumonia is a viral respiratory infection caused by the metapneumovirus. Common symptoms include:
- Fever
- Cough
- Shortness of breath
- Congestion
- Sore throat
To diagnose metapneumonia, a patient needs to undergo the Metapneumonia RNA Detection Qualitative Test. Prior to the test, the patient is required to sign a Consent document and bring any clinical history of the patient.
Report Delivery
Once the sample is collected, the report will be delivered within the following timeframes:
- 3rd Working Day via Email (36 hours)
- On phone: 24 hours
Test Department and Doctor
The Metapneumonia RNA Detection Qualitative Test is conducted by our Genetics Test Department, under the supervision of a Physician.
Overall, the RNA detection qualitative test for metapneumonia plays a crucial role in identifying infected individuals, guiding appropriate treatment, and implementing necessary infection control measures to prevent the spread of the virus.
| Test Name | Metapneumonia RNA Detection Qualitative Test |
|---|---|
| Components | |
| Price | 1160.0 AED |
| Sample Condition | Bronchial Swab, Bronchial Lavage, Sputum, Nasopharyngeal (NP) aspirates and swabs in viral transport medium, or lung tissues, ETC. |
| Report Delivery | 3rd Working Day Email:-36 hours.On phone: 24 hours |
| Method | Real Time PCR |
| Test type | Viral |
| Doctor | Physician |
| Test Department: | Genetics |
| Pre Test Information | Need to sign Consent document and bring any clinical history of patient forMetapneumonia (RNA Detection) QualitativeTest |
| Test Details | Metapneumonia is a viral respiratory infection caused by the metapneumovirus. The RNA detection qualitative test is a diagnostic tool used to detect the presence of metapneumovirus RNA in a patient’s respiratory sample. The test is typically performed using a technique called reverse transcription-polymerase chain reaction (RT-PCR). This method involves the conversion of the viral RNA into complementary DNA (cDNA) using an enzyme called reverse transcriptase. The cDNA is then amplified using PCR, which makes multiple copies of the target viral RNA sequence. During the test, a respiratory sample, such as a nasal swab or sputum, is collected from the patient. The sample is then processed in the laboratory to extract the viral RNA. The extracted RNA is converted into cDNA using reverse transcriptase, and the cDNA is amplified using PCR. If the metapneumovirus RNA is present in the sample, the amplification process will generate a specific DNA product that can be detected using various methods, such as gel electrophoresis or fluorescent probes. The presence of the DNA product indicates a positive result, indicating that the patient is infected with metapneumovirus. The RNA detection qualitative test is highly sensitive and specific, allowing for the early and accurate diagnosis of metapneumonia. It is particularly useful in detecting the virus in patients with mild or asymptomatic infections, who may not exhibit obvious symptoms but can still transmit the virus to others. Overall, the RNA detection qualitative test for metapneumonia plays a crucial role in identifying infected individuals, guiding appropriate treatment, and implementing necessary infection control measures to prevent the spread of the virus. |
